Resolve Nanotherapeutics
1 known investors
Resolve Nanotherapeutics is developing RNA drugs delivered via lipid nanoparticles that amplify the body's toxin-clearance pathway to treat severe acute bacterial infections and their chronic complications. Its host-focused therapy targets the immune system rather than the bacteria, aiming to work against antibiotic-resistant infections in critical care settings.
Investors · 1
Frequently asked questions
- What does Resolve Nanotherapeutics do?
- Resolve Nanotherapeutics is developing RNA drugs delivered via lipid nanoparticles that amplify the body's toxin-clearance pathway to treat severe acute bacterial infections and their chronic complications. Its host-focused therapy targets the immune system rather than the bacteria, aiming to work against antibiotic-resistant infections in critical care settings.
- Who are Resolve Nanotherapeutics's investors?
- Resolve Nanotherapeutics's investors include Innovation UBC.